StonvexLoading…
StonvexStonvexStonvexCore line items from LASE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.34M | $3.42M | $3.94M | $3.89M |
Operating Income | $-13.29M | $-6.46M | $-3.35M | $-2.07M |
Net Income | $-17.46M | $-2.52M | $-3.32M | $-2.09M |
EPS (Diluted) | $-1.02 | $-0.22 | $-0.37 | $-0.37 |
Total Assets | $9.45M | $17.15M | $15.12M | $18.58M |
Total Liabilities | $14.49M | $6.94M | $1.19M | $1.45M |
Cash & Equivalents | $650.34K | $533.87K | $6.20M | $12.18M |
Free Cash Flow OCF − CapEx | $-6.41M | $-9.49M | $-5.55M | $-752.63K |
Shares Outstanding | 22.85M | 14.26M | 9.23M | 7.88M |